Stine Bordier Høj
Biographic Data
| ID | 6679009 |
|---|---|
| NAME | Stine Bordier Høj |
| GIVEN NAMES | Stine Bordier |
| FAMILY NAME | Høj |
| SIGNATURE | HØJ S B |
| AFFILIATIONS | Centre Hospitalier de l’Université de Montréal |
| ORCID | 0000-0002-5403-8341 |
| VERIFIED | Yes |
| TOTAL WORKS | 18 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 18 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Peer-led recruitment for equitable engagement of people who inject drugs: Evidence from the Hepco cohort in Montreal, Canada
BACKGROUND: Engaging people who inject drugs (PWID) in research is challenging due to stigma, distrust, and structural barriers. Peer-led recruitment may enhance reach and equity, yet few studies have quantitatively evaluated its outcomes. METHODS: Between Feb 2021-Dec 2023, a Partnerships Lead with Lived Experience implemented three new recruitment strategies within the HEPCO cohort study of PWID in Montreal, Canada. Strategies extended research…
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced un…
Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: A qualitative study among people who inject drugs and service providers
The application of an intersectionality lens provides a nuanced understanding of multilevel barriers and enablers to point-of-care HCV testing. Findings underscore the need for tailored strategies that address stigma, improve provider roles and communication, and foster an inclusive environment for equitable HCV care. Using an intersectionality lens in implementation research can offer valuable insights, guiding the design of equity-focused imple…
Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved
The online version contains supplementary material available at 10.1007/s11469-023-01207-7
Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Treatment initiation rates have increased since the introduction of universal DAA coverage, though barriers such as incarceration persist
Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use
Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to Covid-19
BACKGROUND: "Big Events" are major disruptions to physical, political, and economic environments that can influence vulnerability to drug-related harms. We reviewed the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services. METHODS: We conducted a rapid review of quantitative, qualitative, and mixed methods literature relating to the following Big Even…
Relative ‘greenness’ and not availability of public open space buffers stressful life events and longitudinal trajectories of psychological distress
Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada
Objectives. To determine the number of people who inject drugs (PWID) in Canada and the annual coverage of opioid agonist treatment (OAT) and needle-and-syringe provision for PWID. Methods. We estimated the number of PWID in 11 of 13 Canadian provinces and territories in 2011 by using indirect multiplier methods based on provincial and territorial methadone recipient totals and proportion of surveyed PWID receiving methadone. We modeled annual in…
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs
Communicating the Sustainability Message to the Public: Lessons from Marketing
Communicating the Sustainability Message to the Public: Lessons from Marketing
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs
Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada
Objectives. To determine the number of people who inject drugs (PWID) in Canada and the annual coverage of opioid agonist treatment (OAT) and needle-and-syringe provision for PWID. Methods. We estimated the number of PWID in 11 of 13 Canadian provinces and territories in 2011 by using indirect multiplier methods based on provincial and territorial methadone recipient totals and proportion of surveyed PWID receiving methadone. We modeled annual in…
Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada
Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use
Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to Covid-19
BACKGROUND: "Big Events" are major disruptions to physical, political, and economic environments that can influence vulnerability to drug-related harms. We reviewed the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services. METHODS: We conducted a rapid review of quantitative, qualitative, and mixed methods literature relating to the following Big Even…
Relative ‘greenness’ and not availability of public open space buffers stressful life events and longitudinal trajectories of psychological distress
Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved
The online version contains supplementary material available at 10.1007/s11469-023-01207-7
Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Treatment initiation rates have increased since the introduction of universal DAA coverage, though barriers such as incarceration persist
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: A qualitative study among people who inject drugs and service providers
The application of an intersectionality lens provides a nuanced understanding of multilevel barriers and enablers to point-of-care HCV testing. Findings underscore the need for tailored strategies that address stigma, improve provider roles and communication, and foster an inclusive environment for equitable HCV care. Using an intersectionality lens in implementation research can offer valuable insights, guiding the design of equity-focused imple…
Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada
Peer-led recruitment for equitable engagement of people who inject drugs: Evidence from the Hepco cohort in Montreal, Canada
BACKGROUND: Engaging people who inject drugs (PWID) in research is challenging due to stigma, distrust, and structural barriers. Peer-led recruitment may enhance reach and equity, yet few studies have quantitatively evaluated its outcomes. METHODS: Between Feb 2021-Dec 2023, a Partnerships Lead with Lived Experience implemented three new recruitment strategies within the HEPCO cohort study of PWID in Montreal, Canada. Strategies extended research…
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced un…
HIV, Drug Use, Sexual Risk (15 works) · Medicine (15 works) · Environmental health (10 works) · Internal Medicine (9 works) · Demography (8 works) · Cohort (7 works) · Hepatitis C virus research (7 works) · Demography (6 works) · Opioid Use Disorder Treatment (6 works) · Psychiatry (6 works)